Sven-Erik Svehag
Corporate Officer/Principal chez University of Southern Denmark
Profil
Sven-Erik Svehag is currently working as a Principal at the World Health Organization, a Professor at the University of Southern Denmark, and an Associate Professor at the National Bact.
Laboratory.
Previously, he worked as the Chief Executive Officer at Profylakse ApS and as the President of the Scandinavian Society of Immunology.
Postes actifs de Sven-Erik Svehag
| Sociétés | Poste | Début |
|---|---|---|
| University of Southern Denmark | Corporate Officer/Principal | - |
World Health Organization
 World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - |
| National Bact. Laboratory | Corporate Officer/Principal | 14/08/2009 |
Anciens postes connus de Sven-Erik Svehag
| Sociétés | Poste | Fin |
|---|---|---|
Profylakse ApS
 Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Directeur Général | 22/11/2013 |
| Scandinavian Society of Immunology | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
World Health Organization
World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Government |
Profylakse ApS
Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
| Scandinavian Society of Immunology | |
| National Bact. Laboratory |